The MIRIAD dataset based its diagnosis of probable AD on the NINCDS-ADRDA clinical Criteria (McKhann et al., 1984), due to the lack of biomarker data (e.g., amyloid β and pathological tau) available for a pathologically confirmed diagnosis. Here, MAPT is linked to Alzheimer disease.